CCH

Wolters Kluwer CCH® Tagetik Expert Solution Named Market Leader in Global and DACH BARC Score Financial Performance Management Reports for 6th Consecutive Year

Retrieved on: 
Thursday, March 30, 2023

Wolters Kluwer , a global leader in information, software, and services for professionals, today announces that its CCH® Tagetik expert solution has retained its leadership position for the sixth consecutive year in both the Global and DACH region categories of the prestigious BARC Score Financial Performance Management (FPM) Report .

Key Points: 
  • Wolters Kluwer , a global leader in information, software, and services for professionals, today announces that its CCH® Tagetik expert solution has retained its leadership position for the sixth consecutive year in both the Global and DACH region categories of the prestigious BARC Score Financial Performance Management (FPM) Report .
  • The BARC Score FPM Global Report evaluates the global market of FPM solution providers, and the localized DACH version assesses solution providers in the DACH region (consisting of Germany, Austria, and Switzerland) only.
  • In both reports, BARC analysts review data and insights from the BARC Planning Survey, the BARC BI & Analytics Survey, and customer feedback to rate solution providers on architecture, functionality, performance, and customer satisfaction.
  • The report reinforces that CCH Tagetik is particularly well-suited for mid-sized and large companies, and groups of affiliated companies, with many users.

Connecticut Department of Emergency Services and Public Protection, in partnership with GCOM, completes first phase of the state’s Clean Slate initiative

Retrieved on: 
Tuesday, March 14, 2023

Under this contract, IDEMIA provides integrated services and components that seamlessly integrate with Connecticut’s master system.

Key Points: 
  • Under this contract, IDEMIA provides integrated services and components that seamlessly integrate with Connecticut’s master system.
  • This flexibility allowed GCOM to rapidly adjust to Connecticut’s legislative developments and support the state’s Clean Slate initiative.
  • These cannabis erasures mark the first phase in Connecticut’s robust Clean Slate initiative.
  • The Clean Slate automated erasure system is expected to be fully implemented during the second half of 2023.

Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis

Retrieved on: 
Monday, March 13, 2023

DUBLIN, March 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in participants with plantar fibromatosis.

Key Points: 
  • DUBLIN, March 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in participants with plantar fibromatosis.
  • The primary endpoint was improvement from baseline in the Foot Function Index (FFI) Pain Scale score when compared to those receiving placebo.
  • The CCH safety profile in the Phase 2 clinical study was consistent with the known CCH safety profile from other studies.
  • "The Phase 2 clinical study data will help us refine our Phase 3 clinical study design, and we plan to begin the pivotal program later this year.

Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis

Retrieved on: 
Monday, March 13, 2023

DUBLIN, March 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in participants with plantar fibromatosis.

Key Points: 
  • DUBLIN, March 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in participants with plantar fibromatosis.
  • The primary endpoint was improvement from baseline in the Foot Function Index (FFI) Pain Scale score when compared to those receiving placebo.
  • The CCH safety profile in the Phase 2 clinical study was consistent with the known CCH safety profile from other studies.
  • "The Phase 2 clinical study data will help us refine our Phase 3 clinical study design, and we plan to begin the pivotal program later this year.

Wolters Kluwer appoints divisional CEOs, creates fifth division dedicated to Corporate Performance and ESG

Retrieved on: 
Monday, March 6, 2023

Wolters Kluwer appoints divisional CEOs, creates fifth division

Key Points: 
  • Wolters Kluwer appoints divisional CEOs, creates fifth division
    Alphen aan den Rijn — March 6, 2023 —Wolters Kluwer, a leading software solutions and services provider, announced today three divisional CEO appointments that will set the stage for accelerated growth at the company.
  • Karen Abramson , formerly CEO of Tax & Accounting, is now the CEO of the new Corporate Performance & ESG (CP & ESG) division.
  • Steve Meirin k , formerly leading Compliance Solutions, is the new CEO of Wolters Kluwer Financial & Corporate Compliance.
  • The appointments follow Wolters Kluwer’s strategic decision announced in February of this year to create a 5th division, Corporate Performance & ESG (CP & ESG).

New Synthetic Biology Company TheraSyn Bio Launches to Transform Industries and Solve Global Challenges

Retrieved on: 
Wednesday, March 1, 2023

, March 1, 2023 /PRNewswire/ -- A group of experienced scientists and entrepreneurs have announced the launch of a new synthetic biology company, TheraSyn Bio, Inc., with the mission to revolutionize the way we address global challenges through advanced biotechnology.

Key Points: 
  • , March 1, 2023 /PRNewswire/ -- A group of experienced scientists and entrepreneurs have announced the launch of a new synthetic biology company, TheraSyn Bio, Inc., with the mission to revolutionize the way we address global challenges through advanced biotechnology.
  • The company aims to leverage cutting-edge synthetic biology to develop innovative solutions for a range of industries,  including precision healthcare solution, agriscience, and environmental sustainability.
  • With a team of world-class experts in the field of synthetic biology, TheraSyn Bio is uniquely positioned to tackle some of the most pressing challenges facing our society today.
  • "At TheraSyn Bio we are committed to harnessing the power of synthetic biology to create a better world for all."

Cheniere Reports Fourth Quarter and Full Year 2022 Results and Introduces Full Year 2023 Financial Guidance

Retrieved on: 
Thursday, February 23, 2023

Our ownership interest in Cheniere Partners as of December 31, 2022 consisted of 100% ownership of the general partner and a 48.6% limited partner interest.

Key Points: 
  • Our ownership interest in Cheniere Partners as of December 31, 2022 consisted of 100% ownership of the general partner and a 48.6% limited partner interest.
  • As of December 31, 2022, our total consolidated available liquidity was approximately $9.9 billion.
  • We had cash and cash equivalents of $1.4 billion on a consolidated basis, of which $904 million was held by Cheniere Partners.
  • In January 2023, the remaining outstanding principal amount of $498 million of the 2024 CCH Senior Notes was redeemed with cash on hand.

Singapore Budget 2023 insights and analysis: Wolters Kluwer shares market-first reports highlighting key provisions

Retrieved on: 
Wednesday, February 15, 2023

Wolters Kluwer , a global leader in professional information, software solutions and services, today provided tax and HR professionals with access to two comprehensive reports.

Key Points: 
  • Wolters Kluwer , a global leader in professional information, software solutions and services, today provided tax and HR professionals with access to two comprehensive reports.
  • The Wolters Kluwer Singapore Budget 2023 – Tax Report shares expert insights and a high-level summary of the budget’s new business tax, personal tax and tax incentives.
  • The Wolters Kluwer Singapore Budget 2023 – HR (Employment Law) Report shares expert insights on the Budget’s short- and long-term measures intended to invest in the economy and workers, including job growth incentives, and jobs.
  • Izzy Silva, Managing Director, Wolters Kluwer Tax & Accounting, Asia Pacific, said:
    “The market-first issuance of these two 2023 Singapore Budget reports underscores Wolters Kluwer’s commitment to providing our tax and accounting firm clients with real-time, rapid access to trusted, high-quality, accurate information and analysis that empowers them to make informed decisions on behalf of their businesses and clients.”

Cross Country CEO Featured on Staffing Industry Analysts' 100 in Staffing List For 2023

Retrieved on: 
Wednesday, February 15, 2023

Cross Country Healthcare (CCH) (NASDAQ: CCRN), a market-leading, tech-enabled workforce solutions platform and advisory firm, is proud to announce that John A. Martins has been recognized on the Staffing Industry Analysts' (SIA) Staffing 100 list of the most influential people in the staffing industry.

Key Points: 
  • Cross Country Healthcare (CCH) (NASDAQ: CCRN), a market-leading, tech-enabled workforce solutions platform and advisory firm, is proud to announce that John A. Martins has been recognized on the Staffing Industry Analysts' (SIA) Staffing 100 list of the most influential people in the staffing industry.
  • View the full release here: https://www.businesswire.com/news/home/20230213005439/en/
    Cross Country CEO, John A. Martins, has been recognized on the SIA Staffing 100 list of the most influential people in the staffing industry.
  • (Photo: Business Wire)
    “I am honored to be included on the Staffing 100 list this year alongside so many of my esteemed peers,” said John A. Martins, President and CEO of Cross Country Healthcare.
  • Staffing Industry Analysts (SIA), the global advisor on staffing and workforce solutions, has published its 12th annual list of North American staffing leaders, honoring 100 notable individuals who are elevating the industry and advancing the workforce solutions ecosystem through their accomplishments.

Nine Organizations Sign with MEDITECH’s Expanse MaaS Platform in Q4 2022

Retrieved on: 
Thursday, January 26, 2023

The subscription-based MEDITECH as a Service (MaaS) solution is continuing to provide value and efficiency to organizations moving to the Expanse EHR.

Key Points: 
  • The subscription-based MEDITECH as a Service (MaaS) solution is continuing to provide value and efficiency to organizations moving to the Expanse EHR.
  • Overall, 2022 saw an increase of 45% in the total number of organizations licensing MEDITECH's MaaS platform (compared to all previous years).
  • The upgrade to Expanse will provide seamless integration across their care delivery settings, including acute, ambulatory, home care , and hospice.
  • In addition to its nine MaaS signings, several additional healthcare organizations also signed for Expanse in Q4, including Cherry County Hospital and Clinic (Valentine, NE).